Author(s):
Mahek D., Pooja K., Shital F.
Email(s):
phsmile12@gmail.com
DOI:
10.52711/2321-5836.2025.00022
Address:
Mahek D.1, Pooja K.2*, Shital F.3
1B. Pharm Scholar, Smt. R. D. Gardi B. Pharmacy College, Gujarat Technological University, Rajkot, Gujarat, India.
2Professor, Department of Pharmacognosy, Smt. R. D. Gardi B. Pharmacy College, Gujarat Technological University, Rajkot, Gujarat, India.
3Principal, Smt. R. D. Gardi B. Pharmacy College, Gujarat Technological University, Rajkot, Gujarat, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
Progeria is a rare genetic disorder that causes premature aging in children. A little genetic mutation is the disease's etiology. Aging-related symptoms like wrinkles and baldness are brought on by progeria. It's always a fatal disease. Heart attacks and strokes are the leading causes of death. One medication that may slow down the disease's course is lonafarnib.
Cite this article:
Mahek D., Pooja K., Shital F. An Overview of Hutchinson - Gilford Progeria Syndrome. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):137-3. doi: 10.52711/2321-5836.2025.00022
Cite(Electronic):
Mahek D., Pooja K., Shital F. An Overview of Hutchinson - Gilford Progeria Syndrome. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):137-3. doi: 10.52711/2321-5836.2025.00022 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-9
REFERENCE:
1. Ulrich, N. J., and Gordon, L. B. (2015). Hutchinson–Gilford progeria syndrome. In Handbook of Clinical Neurology (pp. 249–264). https://doi.org/10.1016/b978-0-444-62702-5.00018-4
2. Liu GH, Suzuki K, Qu J, Sancho-Martinez I, Yi F, Li M, Kumar S, Nivet E, Kim J, Soligalla RD, Dubova I, Goebl A, Plongthongkum N, Fung HL, Zhang K, Loring JF, Laurent LC, Izpisua Belmonte JC. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell. 2011 Jun 3; 8(6):688-94. doi: 10.1016/j.stem.2011.04.019.
3. Liu GH, Ding Z, Belmonte JC. iPSC technology to study human aging and aging-related disorders. Current Opinion in Cell Biology. 2012 Dec 1; 24(6): 765-74.
4. Progeria. Cleveland Clinic. 2024. Available from: https://my.clevelandclinic.org/health/diseases/17850-progeria
5. Progeria - Symptoms and causes - Mayo Clinic. Mayo Clinic. 2023. Available from: https://www.mayoclinic.org/diseases-conditions/progeria/symptoms-causes/syc-20356038
6. Cisneros, B., Garcia‐Aguirre, I., De Iota, M., Arietta‐Cruz, I., and Rosas-Vargas, H. Hutchinson-Gilford Progeria Syndrome: Cellular mechanisms and therapeutic Perspectives. Archives of Medical Research. 2023; 54(5): 102837. https://doi.org/10.1016/j.arcmed.2023.06.002
7. Foo, M. X. R., Ong, P., and Dresden, O. Premature aging syndromes: Frompatient’smechanism. Journal of Dermatological Science. 2019; 96(2): 58–65.
8. The Progeria Research Foundation. For the Children For the Cure. 2024. Available from: https://www.progeriaresearch.org/
9. JK Sinha, S Ghosh, M. Raghunath. Progeria: a rare genetic premature aging disorder Indian J Med Res. 2014; 139: 667-674. Available-from- https://www.mayoclinic.org/diseasesconditions/progeria/symptoms-causes/syc-20356038
10. Lamis A, Siddiqui SW, Ashok T, Patni N, Fatima M, Aneef AN. Hutchinson-Gilford Progeria Syndrome: A Literature Review. Cureus. 2022 Aug 31; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524302/
11. The Progeria Research Foundation. Progeria 101 FAQ | The Progeria Research Foundation [Internet]. The Progeria Research Foundation. 2024. Available from: https://www.progeriaresearch.org/progeria-101faq/
12. Progeria: a new kind of Laminopathy-- report of the First European Symposium on Progeria and creation of EURO-Progeria, a European Consortium on Progeria and related disorders. Brunet T, Bonne G, Denecke J, et al. https://pubmed.ncbi.nlm.nih.gov/16429102/ Podiatry Endocrinal Rev. 2004; 2: 39–45.
13. Gordon LB, Brown WT, Collins FS. Hutchinson-Gilford Progeria Syndrome. Seattle, WA: Gene Reviews; 1993. Hutchinson-Gilford Progeria Syndrome.
14. Kara N Shah, M. (2020, December 28. Hutchinson-Gilford Progeria Workup. 2020. https://emedicine.medscape.com/article/1117344-workup
15. Dhillon S. Lonafarnib: First Approval. Drugs. 2021 Feb; 81(2): 283-289. doi: 10.1007/s40265-020-01464-z. Erratum in: Drugs. 2021 Apr; 81(5):619. doi: 10.1007/s40265-021-01500-6. PMID: 33590450; PMCID: PMC7985116.
16. Hennekam RCM. Hutchinson–Gilford progeria syndrome: Review of the phenotype. American Journal of Medical Genetics Part A. 2006 Jul 12; 140A(23): 2603–2624. Available from: https://doi.org/10.1002/ajmg.a.31346
17. Shah KN. Hutchinson-Gilford Progeria: Practice Essentials, background, Pathophysiology. Available from: https://emedicine.medscape.com/article/1117344-overview?form=fpf#a1
18. Pereira S, Bourgeois P, Navarro C, Estevez-Vieira V, Chau P, De Sandre-Giovannoli A. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev. 2008; 129(7-8): 449-59.
19. DE chat T, Pfleghaar K, Sengupta K, et al. nuclear laminas: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 2008 Apr 1; 22(7):832-53.
20. Sickles CK, Gross GP. Progeria. StatPearls - NCBI Bookshelf. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507797/
21. Gang L, Liu Z, Zhang W, Li W, Wu Z, Wang W, Ren R, Su Y, Wang P, Sun L, Jiu Z, Chan P, Song M, Qu J, Liu GH. A chemical screen identifies a neuroprotective role of quercetin in premature aging. Protein Cell. 2019 Jun; 10(6): 417-435.
22. Oshawa J, Kato H, Tazawa Y, Yoke K. RECQ helicase disease and related progeria syndromes: RECQ2018 meeting. Mech Ageing Dev. 2018 Jul; 173: 80-83.
23. Sharma B, Sharma P, Joshi SC. Risk Factors, Prevalence and Diagnosis of Hutchison Gilford Syndrome with Special Reference To Case Reports. International Journal of Pharmacy and Pharmaceutical Sciences. 2017 May 1; 9(5): 1. Available from: https://doi.org/10.22159/ijpps.2017v9i5.16282
24. Progeria Research Foundation (PRF) webpage. Available from: http://www.progeriaresearch.org/meet_the_kids.html.
25. The Progeria Research Foundation. The Progeria Research Foundation - For the Children. For the Cure. The Progeria Research Foundation. 2024. Available from: http://www.progeriaresearch.org/progeria_101
26. Brown WT. Progeria: a human disease model of accelerated aging. Am J Clin Nutria. 1992; 55: 1222S–4S.
27. Gordon CM, Gordon LB, Snyder BD, Nazarene A, Quinn N, Huh S, et al. Hutchinson-Gilford progeria is a skeletal dysplasia. J Bone Miner Res. 2011 Jul. 26(7): 1670-9.
28. Ding SL, Shen CY. Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes. Clan Intern Aging. 2008. 3(3): 431-44.
29. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003 May 15; 423(6937): 293-8. doi: 10.1038/nature01629. Epub 2003 Apr 25. PMID: 12714972; PMCID: PMC10540076.
30. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Lévy N. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003 Jun 27; 300(5628): 2055. doi: 10.1126/science.1084125. Epub 2003 Apr 17. PMID: 12702809.
31. Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. Nuclear lamins: building blocks of nuclear architecture. Genes Dev. 2002 Mar 1; 16(5): 533-47. doi: 10.1101/gad.960502. PMID: 11877373.
32. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol. 2005 Jan; 6(1): 21-31. doi: 10.1038/nrm1550. PMID: 15688064.
33. Dai Q, Choy E, Chiu V, Romano J, Slivka SR, Steitz SA, Michaelis S, Philips MR. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem. 1998 Jun 12; 273(24): 15030-4. doi: 10.1074/jbc.273.24.15030. PMID: 9614111.
34. Mallampalli MP, Huyer G, Bendale P, Gelb MH, Michaelis S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA. 2005 Oct 4; 102(40): 14416-21. doi: 10.1073/pnas.0503712102. Epub 2005 Sep 26. PMID: 16186497; PMCID: PMC1242289.
35. Glynn MW, Glover TW. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet. 2005 Oct 15; 14(20): 2959-69. doi: 10.1093/hmg/ddi326. Epub 2005 Aug 26. PMID: 16126733.
36. Röber RA, Weber K, Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development. 1989 Feb; 105(2): 365-78. doi: 10.1242/dev.105.2.365. PMID: 2680424.
37. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, Collins FS. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA. 2004 Jun 15; 101(24): 8963-8. doi: 10.1073/pnas.0402943101. Epub 2004 Jun 7. PMID: 15184648; PMCID: PMC428455.
38. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med. 2005 Apr; 11(4): 440-5. doi: 10.1038/nm1204. Epub 2005 Mar 6. PMID: 15750600; PMCID: PMC1351119.
39. McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamina A primarily targets human vascular cells as detected by an anti-Lamina a G608G antibody. Pros Natl Accad Sic USA. 2006 Feb 14. 103(7): 2154-9.
40. Olive M, Herten I, Mitchell R, Beers JK, Djabali K, Cao K, et al. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. ArteriosclerosisThrombiVacs Biol. 2010 Nov. 30(11): 2301-9.
41. Gerhard-Herman M, Smoot LB, Wake N, Kieran MW, Klein man ME, Miller DT, et al. Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome. Hypertension. 2012 Jan. 59(1): 92-7.
42. Willaume S, Rass E, Fontanilla-Ramirez P, Moussa A, Wanschoor P, Bertrand P. A Link between Replicative Stress, Lamin Proteins, and Inflammation. Genes [Internet]. 2021 Apr 9; 12(4): 552. Available from: https://doi.org/10.3390/genes12040552
43. Progeria. Cleveland Clinic. 2024. Available from: https://my.clevelandclinic.org/health/diseases/17850-progeria
44. ABC Medical Center. Progeria: causes, symptoms, and treatment options | ABC Medical Center. ABC Medical Center. 2024. Available from: https://centromedicoabc.com/en/padecimientos/progeria/#signs-and-%20%20%20%20%20symptoms-progenitor
45. Progeria - Diagnosis and treatment - Mayo Clinic. 2023. Available from: https://www.mayoclinic.org/diseases-conditions/progeria/diagnosis-treatment/drc-20356043
46. Restage R, Chandler Mohan SM. Progeria syndrome: a case report. Indian J Orthoepy. 2008; 42: 97-9.
47. Henniker RCM. Hutchinson–Gilford progeria syndrome: a review of the phenotype. Is J Med Genet. 2006; 140: 2603-24
48. Meredith MA, Gordon LB, Claus’s S, Sachem V, Smith AC, Perry MB, et al. Phenotype and course of Hutchinson-Gilford progenies syndrome. N Engle J Med. 2008; 358: 592–604.
49. Gordon LB, McCartney KM, Giobbie-Hurder A. Disease progression in Hutchinson-Gilford progenies syndrome: impact on growth and development. Paediatrics. 2007; 120:824-33
50. Brown WT, Brower M, Kieran FJ. Progenies: a genetic disease model of premature aging. In: Harrison DE. Ed. Genetic Effects on Aging II; 1990. p. 521-42.
51. Gordon LB, Herten IA, Calibri A, Sukumaran G, Coca AB, Brown WT, et al. Hyaluronic is not elevated in urine or serum in Hutchinson-Gilford progenies syndrome. Hum Genet. 2003; 113: 178–87.
52. Gary MD, Sheen JC, Klamath-Loeb AS, Blank A, Sop her BL, Martin GM, et al. The Werner syndrome protein is DNA helices. Nat Genet. 1997; 17:100-3.
53. Gordon LB, Chappell H, Mossoro J, Agostino RB Sir, Brazier J, Campbell SE, et al. Association of Lonafarnib Treatment vs. No Treatment with Mortality Rate in Patients with Hutchinson-Gilford Progenies Syndrome. JAMA. 2018 Apr 24. 319 (16):1687-1695.
54. Rupa Bhattacharya, Samira R. Khan. Review on Progeria: A Rare Genetic Premature Aging Disorder. Res. J. Pharmacology and Pharmacodynamics. 2020; 12(2): 73-82.
55. Gayathri S. Effectiveness of Structured Teaching Programme on Care of Children with Genetic Disorders among III year B.Sc. Nursing students of RMCON, Chidambaram. Asian J. Nur. Edu. and Research 2016; 6(1): 79-80.
56. Kavitha D. Osteogenesis Imperfecta. Int. J. of Advances in Nur. Management. 2020; 8(4): 347-349.
57. Veerabhadrappa G Mendagudli. A Comprehensive Review of Down Syndrome: Molecular Basis, Clinical Characteristics and Therapeutic Prospects. International Journal of Advances in Nursing Management. 2024; 12(2): 99-0.
58. Bhawana. B. Bhende. Article on Tay-Sachs Disease. International Journal of Nursing Education and Research. 2021; 9(4): 475-8.
59. Bhagya Sree Lekha Annamneedi, Abhiram Sorra, Vinod Kumar Mugada, Srinivasa Rao Yarguntla. Wolfram Syndrome: A Rare Genetic disorder affecting Multiple Organ Systems. Research Journal of Pharmacology and Pharmacodynamics.2023; 15(4): 172-8.
60. Nigama Chandra Sattenapalli, Ranjit Prasad Swain, Siva Naga Koteswara Rao Gudhanti. Bridging between disorder, prevalence, clinical manifestation and therapeutic management of muscular dystrophy. Research Journal of Pharmacy and Technology. 2022; 15(11): 4901-7.
61. Sedigheh Iranmanesh, Ala Shamsi. The Relationship between Type of Cancer and Parent's Psychosocial Risks. Asian J. Nur. Edu. and Research. 2014; 4(4): 495-501.
62. Vinod V. Bagilkar, Bharatesh B. Savadatti. A descriptive study on Malnutrition. Asian J. Nur. Edu. and Research. 2015; 5(1): 72-77.
63. Proshob Mathew, Chandrashekar M. A Study to Assess the Emotional and Behavioral problems among Overweight Children in Selected Schools at Mysuru. Asian J. Nur. Edu. and Research. 2015; 5(4): 451-456
64. Anitha Rose Sunny, Anumol Varghese, Anusha Valsan, Benazeera, Asha P Shetty. Oral Health Status and Self reported Oral Hygienic Practices among School Children. Asian J. Nur. Edu. and Research. 2016; 6(3): 351-355